Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Freeman Chris, Directeur Commercial. Insider active across 1 company, notably Guardant Health, Inc.. Aggregated, 35 disclosures have been recorded. Split: 0 buy · 5 sells. Total volume traded: €9.4m. History available since 15 June 2022. The latest transaction was disclosed on 10 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Freeman Chris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Freeman Chris is Director Commercial and Chief Commercial Officer at Guardant Health, Inc. He has 29 filings in total, and in the sampled recent filings the sell volume is EUR 41642, covering the period from 2022-06-17 to 2026-06-16. The most common transaction nature is option exercise.